The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension

Expert Review of Cardiovascular Therapy
Shilpa A DeSouza, Ioana R Preston

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is an insidious, progressive disease with a poor prognosis. The treatment of choice is pulmonary thromboendarterectomy, although not all patients benefit from surgery at a specialized center. Riociguat, an oral soluble guanylate cyclase (sGC) stimulator is the first pharmacotherapeutic agent that has been shown to improve exercise capacity and hemodynamics in a large multicenter, double-blind, randomized placebo-controlled trial for the treatment of patients with inoperable or persistent CTEPH. Riociguat stimulates sGC directly in a nitric oxide (NO)-independent manner, thereby increasing the sensitivity of sGC to NO, and also in synergy with NO, leading to increased production of cyclic guanosine monophosphate, an intracellular messenger involved in regulating vascular tone, smooth muscle cell proliferation, fibrosis and inflammation. This review will summarize the pharmacodynamics, pharmacokinetics as well as safety and efficacy data of riociguat in inoperable or persistent CTEPH.

References

Aug 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·W P ArnoldF Murad
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Dec 1, 1996·The Annals of Thoracic Surgery·A M AtzD L Wessel
Jan 17, 2002·The New England Journal of Medicine·P F FedulloL J Rubin
Aug 2, 2002·The New England Journal of Medicine·Horst OlschewskiUNKNOWN Aerosolized Iloprost Randomized Study Group
Oct 1, 2005·Circulation Research·Thomas MünzelAlexander Mülsch
Nov 18, 2005·The New England Journal of Medicine·Nazzareno GalièUNKNOWN Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group
Feb 2, 2006·Scandinavian Cardiovascular Journal : SCJ·Søren MellemkjaerBent O Kristensen
Apr 26, 2006·Circulation·Marius M HoeperLewis J Rubin
Sep 12, 2006·Proceedings of the American Thoracic Society·Eckhard Mayer, Walter Klepetko
Sep 12, 2006·Proceedings of the American Thoracic Society·Andrew PeacockLewis Rubin
Sep 27, 2006·Circulation·Vallerie V McLaughlin, Michael D McGoon
Apr 11, 2007·Circulation·Diana BondermanIrene M Lang
Sep 18, 2007·American Journal of Respiratory and Critical Care Medicine·Nika Skoro-SajerIrene M Lang
Jun 14, 2008·The European Respiratory Journal·R T SchermulyF Grimminger
Oct 3, 2008·Current Opinion in Cardiology·Irene M Lang, Walter Klepetko
Dec 18, 2008·Handbook of Experimental Pharmacology·Hossein-Ardeschir Ghofrani, Friedrich Grimminger
Dec 20, 2008·Journal of the American College of Cardiology·Xavier JaïsUNKNOWN Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group
Jan 9, 2009·The European Respiratory Journal·F GrimmingerH A Ghofrani
Sep 15, 2009·The European Respiratory Journal·N GalièG Simonneau
May 18, 2010·The Journal of Thoracic and Cardiovascular Surgery·Darren H FreedDavid P Jenkins
Mar 1, 2009·European Respiratory Review : an Official Journal of the European Respiratory Society·I M Lang
Mar 1, 2009·European Respiratory Review : an Official Journal of the European Respiratory Society·H A Ghofrani, F Grimminger
Oct 20, 2010·European Respiratory Review : an Official Journal of the European Respiratory Society·J Pepke-Zaba
Oct 20, 2010·European Respiratory Review : an Official Journal of the European Respiratory Society·M Humbert
Feb 22, 2011·The Journal of Thoracic and Cardiovascular Surgery·Eckhard MayerPhilippe Dartevelle
May 25, 2011·Circulation·Johannes-Peter StaschOleg V Evgenov
Oct 8, 2011·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·B SchölzelM Post
Jan 10, 2012·International Journal of Cardiology·Heinrike WilkensEckhard Mayer
May 26, 2012·The Annals of Thoracic Surgery·Michael M MadaniStuart W Jamieson
Nov 8, 2012·Circulation. Cardiovascular Interventions·Masaharu KataokaToru Satoh
Nov 30, 2012·Circulation. Cardiovascular Interventions·Hiroki MizoguchiHiromi Matsubara
Jul 26, 2013·The New England Journal of Medicine·Hossein-Ardeschir GhofraniUNKNOWN CHEST-1 Study Group
Dec 21, 2013·Journal of the American College of Cardiology·Gerald SimonneauRogiero Souza

❮ Previous
Next ❯

Citations

Jun 23, 2015·Pediatric Pulmonology·George M SolomonSteven M Rowe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Drugs
Daniel Conole, Lesley J Scott
The New England Journal of Medicine
Hossein-Ardeschir GhofraniPATENT-1 Study Group
Future Cardiology
Hossein-Ardeschir GhofraniFriedrich Grimminger
© 2021 Meta ULC. All rights reserved